Kurma Partners

Kurma Partners is a leading European venture capital firm founded in 2009, headquartered in Paris, France, with an additional office in Munich, Germany. The firm specializes in financing innovation in healthcare, biotechnology, digital health, and related life sciences sectors. Kurma Partners focuses on early-stage and development capital investments, supporting companies that translate disruptive scientific discoveries into cutting-edge medicines and medical devices aimed at treating severe diseases with high unmet medical needs.

Kurma Partners has built a strong network of partnerships with top European academic research institutions, hospitals, and industrial experts. This collaborative approach enables the firm to guide portfolio companies from concept through clinical development, providing both equity funding and strategic support. The firm manages dedicated funds such as Kurma Biofund, focused on therapeutics, and Kurma Diagnostics, targeting diagnostics and digital health innovations.

With approximately €470 million under management, Kurma Partners has supported over 72 companies and helped create about 25 startups, many of which have become leaders in their respective markets. The firm’s investment strategy spans from seed to growth stages, primarily across Europe, including France, Germany, and broader Southwestern and Southern Europe. Kurma Partners is recognized for its rigorous scientific and business analysis, fostering innovation to improve patient outcomes and address unmet medical needs.